319 results
Page 6 of 16
8-K
EX-99.2
toew5pv ympho
2 Mar 20
Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
7:03am
8-K
EX-99.1
6l6v4tj
2 Mar 20
Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
7:03am
8-K
EX-99.1
n8hpcgpl2e770l136 f6
12 Feb 20
Other Events
5:20pm
8-K
EX-99.1
mxl1j0si28qjgty
7 Feb 20
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposiumâ„¢ 2020
7:01am
8-K
EX-99.2
dj4q 35dimvk
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.1
j7voq2 rh6t10l6d
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.1
xbyftw
9 Jan 20
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
7:03am
8-K
EX-99.1
9stueari01tyvocqi
7 Jan 20
Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
7:01am
8-K
EX-99.1
z6tip8q5e0ew9u8uqee
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
EX-99.2
xkns99pzq6l7jpss2o
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
EX-99.3
18dray oaq9whob
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
EX-99.2
im2uns4eel51
24 Oct 19
Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society
7:00am
8-K
EX-99.1
ylhw9h0yfm1pl qy5h
24 Oct 19
Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society
7:00am